Edwards Lifesciences paid its 6 named executives $41.0M in total in FY2025 (Dec). CEO Mr. Zovighian was paid $17.5M of that.
PayNo stock prices for these years
Pay of each named executive
Mr. ZovighianChief Executive Officer and Director
| FY2025 (Dec) | ||||||
| FY2024 (Dec) | ||||||
| FY2023 (Dec) | ||||||
| FY2022 (Dec) |
4 years
Mr. UllemCorporate Vice President, Chief Financial Officer
| FY2025 (Dec) | ||||||
| FY2024 (Dec) | ||||||
| FY2023 (Dec) | ||||||
| FY2022 (Dec) | ||||||
| FY2021 (Dec) |
5 years
Mr. WoodCorporate Vice President
| FY2025 (Dec) | ||||||
| FY2024 (Dec) | ||||||
| FY2023 (Dec) | ||||||
| FY2022 (Dec) | ||||||
| FY2021 (Dec) |
5 years
Mr. ChopraCorporate Vice President, Transcatheter Mitral and Tricuspid Therapies
| FY2025 (Dec) | ||||||
| FY2024 (Dec) |
2 years
Mr. BoboCorporate Vice President, Strategy & Corporate Development
| FY2025 (Dec) | ||||||
| FY2024 (Dec) | ||||||
| FY2023 (Dec) | ||||||
| FY2022 (Dec) | ||||||
| FY2021 (Dec) |
5 years
Ms. BrülsCorporate Vice President, EMEACLA
| FY2025 (Dec) |
1 year
CEO pay against the pay peers
In FY2025 (Dec), the median CEO pay of the 11 peers with pay on file was $17.1M. The CEO of Edwards Lifesciences was paid $17.5M, 2% above the median.
- 1Abbott Laboratories
- 2Boston Scientific
- 3Stryker
- 4Intuitive Surgical
- 5Align Technology
- 6Edwards LifesciencesThis company
- 7Becton Dickinson & Co
- 8Zimmer Biomet Holdings
- 9Cooper Companies
- 10Resmed
- 11Agilent Technologies
- 12Illumina
- 13Baxter InternationalNot disclosed
- 14DexcomNot disclosed
- 15GE HealthCare TechnologiesNot disclosed
- 16Hologic, Inc.Not disclosed
- 17IDEXX Laboratories, Inc.Not disclosed
- 18MedtronicNot disclosed
'%3e%3cg%20id='Clip-2'%3e%3c/g%3e%3cpolyline%20id='Fill-1'%20class='st0'%20points='0.1,56.1%200.2,148.5%2017.7,148.5%2017.7,56.1%200.1,56.1%20'/%3e%3cpolyline%20id='Fill-3'%20class='st1'%20points='46.9,0.9%2046.9,148.5%2064.6,148.5%2064.6,0.9%2046.9,0.9%20'/%3e%3cpolygon%20id='Fill-4'%20class='st1'%20points='94.7,148.5%20112.4,148.5%20112.4,0.9%2094.7,0.9%20'/%3e%3cpath%20id='Fill-5'%20class='st1'%20d='M219.3,148.5h-17.6v-14.2h-0.4c-10.9,23.8-64,25.9-64-18.7l-0.1-59.5h17.6v54.6%20c0,17.4,10,23.8,21.1,23.8c14.6,0,25.8-9.4,25.7-30.8V56.1h17.6L219.3,148.5'/%3e%3c/g%3e%3cpath%20id='Fill-7'%20class='st1'%20d='M244.9,56.1h16.4v14.4h0.4c1.8-5.5,13.1-16.8,29.7-16.8c13.7,0,23,5.9,28.9,17.2%20c6.1-11.3,18.2-17.2,29.3-17.2c28.5,0,35.1,20.3,35.2,41v53.9h-17.6V97.1c0-14.1-3-26.9-19.9-26.9c-17,0-23.6,11.5-23.6,27.9v50.5%20H306v-48.4c0-17.6-2.6-30-19.5-30c-12.7,0-24,9.6-24,30.4v48h-17.6V56.1'/%3e%3cpolygon%20id='Fill-8'%20class='st1'%20points='408.6,148.5%20426.2,148.5%20426.2,56.1%20408.6,56.1%20'/%3e%3cpath%20id='Fill-9'%20class='st1'%20d='M452.1,56.1h17.6v14.2h0.4c10.9-23.8,64-25.9,64,18.7v59.5h-17.6V93.9c0-17.4-10-23.8-21.1-23.8%20c-14.6,0-25.8,9.4-25.7,30.8v47.6h-17.6L452.1,56.1'/%3e%3cg%20id='Group-13'%20transform='translate(0.000000,%2012.000000)'%3e%3cg%20id='Clip-11'%3e%3c/g%3e%3cpath%20id='Fill-10'%20class='st1'%20d='M567.6,66.3c6.4-4.9,12.9-10.5,26.3-10.5c15,0,22.1,9.9,22.1,19.5v3.9c-17.6,0-63.8-2.5-63.8,32%20c0,18,14.8,27.7,32,27.7c14,0,24.6-4.5,32.4-16.4h0.4c0,4.7,0.2,9.4,0.6,14.1h15.6c-1.3-10.7-0.8-65-0.8-64%20c0-35.6-51.9-39.2-75.3-17.2L567.6,66.3z%20M616.1,92.1V98c0,12.5-6.8,26.9-26.3,26.9c-12.1,0-19.9-4.5-19.9-15%20C569.8,91.3,600.3,92.1,616.1,92.1L616.1,92.1z'/%3e%3cpath%20id='Fill-12'%20class='st0'%20d='M11.8,0C5.3,0,0,5.3,0,11.8s5.3,11.8,11.8,11.8s11.8-5.3,11.8-11.8S18.3,0,11.8,0'/%3e%3c/g%3e%3c/g%3e%3c/svg%3e)
Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.